Cash And Equivalent Changement Date
AbbVie USD 13.29B 4.53B 2023-09
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
ALKERMES USD 647.71M 18.08M 2023-09
Amgen USD 10.94B 23.8B 2023-12
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bluebird Bio USD 165.35M 7.52M 2023-09
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
Exelixis USD 396.86M 67.62M 2023-09
Genmab DKK 14.27B 3.4B 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
J&J USD 3.5B 497M 2023-09
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Amgen Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.